Collaboration and the Cure for Cancer with speakers David Agus and Larry Norton speaking at the 2007 Aspen Ideas Festival. Robin Portman moderates.
In this, its third year, Aspen Ideas Festival once again gathers scientists, artists, politicians, historians, educators, activists, and other great thinkers around some of the most important and fascinating ideas of our time. As these thinkers present their provocative ideas, they engage a sophisticated and highly motivated audience.
Bio
David Agus
David Agus is a professor of medicine at the University of Southern California's Keck School of Medicine, and heads USC's Westside Cancer Center and the Center for Applied Molecular Medicine. His research focuses on the application of proteomics and genomics for the study of cancer and the development of new therapeutics for cancer.
Agus has received many honors, including the American Cancer Society Physician Research Award, a Clinical Scholar Award from the Sloan-Kettering Institute, the International Myeloma Foundation Visionary Science Award, the Health Network Foundation's Excellence Award, and the 2009 GQ magazine Rockstar of Science Award. He is the founder of Oncology.com, the largest cancer Internet resource community, and Applied Proteomics; and co-founder of Navigenics, a genomic health care technology and wellness company. Agus's new book, What is Health?, will be published in September.
Larry Norton
Larry Norton, MD, is deputy physician-in-chief for breast cancer programs at Memorial Sloan-Kettering Cancer Center and medical director of Memorial Sloan-Kettering 64th Street, comprised of the Evelyn H. Lauder Breast Center and the Iris Cantor Diagnostic Center. His research concerns the basic biology of cancer, the mathematics of tumor causation and growth, and developing approaches to better diagnosis, prevention, and drug treatment of the disease. He has also developed a new approach to therapy that uses anticancer drugs based on a mathematical model maximizing the killing of cancer cells while minimizing toxicity. The principal investigator of a grant from the National Cancer Institute to better understand breast cancer in the laboratory and to bring these advances into clinical practice, he has also served on the NCI’s board of directors.
Robin Portman
Robin Portman is a vice president at Booz Allen Hamilton. Portman has more than 15 years of strategy development and technology delivery experience. She leads consulting and technology delivery engagements for the firm’s Global Health business, focusing on clients for both the US federal and commercial health industry including the Department of Health and Human Services, the National Institutes of Health, the Department of Veterans Affairs, and the US Military Health System. Under her leadership, Booz Allen provides technology management, development, and integration for health and research domains, including clinical data management, clinical trials and research study support, collaborative science, biomedical informatics, and electronic health records systems. Portman has published on her breakthrough work in collaborative science in the firm’s quarterly business journal, strategy+business magazine.